Response by Mehra et al to Letter Regarding Article, “Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We are delighted to see Maltais and colleagues express interest in our efforts to enhance depiction of clinical outcomes in the field of mechanical circulatory support. We welcome this opportunity to help clarify several misconceptions that may have arisen from perhaps a perfunctory review of our collective work as referenced by our colleagues.1,2
When the notion of hemocompatibility was first alluded to by Mehra,1 it was designed to develop a clinical definition for this rather complex weave of intersection between bleeding and clotting disorders that form the Achilles heel of clinical application of left ventricular assist systems. The concept paper alluded to the challenges and provided the algorithm for tiered outcomes assessment, which …